Glenmark Pharmaceuticals Inc., USA is recalling 96,948 packs of Ondansetron Orally Disintegrating Tablets (4mg) because the blister pack containers are not fully sealed. This defect causes tablets to fall out of their protective packaging, potentially exposing them to environmental factors or resulting in missing doses. The recall affect 30-count packs (containing three 10-tablet blister cards) which were repackaged by Preferred Pharmaceuticals.
Defective seals on blister packaging can lead to tablet degradation from moisture or air exposure and may result in consumers receiving an empty blister or an incorrect dosage. No specific injuries or adverse reactions have been reported to date.
You have 2 options:
3 blistercards each containing 10 tablets; Rx only; Product of India; Repackaged by Preferred Pharmaceuticals.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.